The JSE faces mixed Asian markets on Wednesday, with sentiment taking a bit of a knock after reports cast doubt on the results of a trial of Moderna’s Covid-19 vaccine.

Oanda senior market analyst Jeffrey Halley agreed with Stat News’ view that the sample size of eight trials was open to various biases, such as age and gender, and was small.

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now